2024-11-26 03:57:43
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax
Corporate/ 2023-07-24
iNtRON has confirmed the efficacy of BAL...

Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack

HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
Corporate/ 2023-07-24
HBM Alpha Therapeutics Raises Seed Round...

CAMBRIDGE,Mass.,Jan. 26,2023--HBM Alpha Therapeutics (HBMAT),Inc.,an innovative biotechnology company incubated by Harbour BioMed (HKEX: 021...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release